Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

APO Medical Opportunities

+ Add to Watchlist

WZFA:GR

130.2900 EUR 0.2900 0.22%

As of 13:04:27 ET on 05/25/2015.

Snapshot for APO Medical Opportunities (WZFA)

Open: 129.7100 High - Low: 130.9300 - 129.7100 Primary Exchange: Frankfurt
Volume: 0 52-Week Range: 100.0000 - 132.4800 Beta vs DAX: 0.6461

ETF Chart for WZFA

No chart data available.
  • WZFA:GR 130.2900
  • 1M
  • 1Y
130.5800
Interactive WZFA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for WZFA

APO Medical Opportunities is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests primarily in equities of companies from the health care sector.

Inception Date: Telephone: 352-260248-1 Tel
Managers: KAI BRUENING / HARALD SCHWARZ
Web Site: www.ipconcept.lu

Fundamentals for WZFA

NAV (on 2015-05-22) 131.1100
Assets (M) (on 2015-05-22) 190.0714
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -0.40
Average 52-Week % Premium -0.6548
Fund Leveraged N

Dividends for WZFA

Dividend Type Omitted
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -%

Performance for WZFA

1-Month +0.41% 1-Year +27.09%
3-Month +7.32% 3-Year +25.72%
Year To Date +14.06% 5-Year +18.61%
Expense Ratio -

Top Fund Holdings for WZFA

Filing Date: 12/31/2014
Name Position Value % of Total
Novartis AG 66,300 5,123,107 2.999%
Roche Holding AG 21,350 4,792,169 2.805%
Amgen Inc 35,200 4,706,725 2.755%
AbbVie Inc 79,800 4,399,189 2.575%
Abbott Laboratories 110,400 4,133,541 2.420%
Bayer AG 33,950 3,905,948 2.286%
Sanofi 47,850 3,631,815 2.126%
BioMarin Pharmaceutical Inc 46,500 3,520,622 2.061%
H Lundbeck A/S 198,800 3,331,679 1.950%
Edwards Lifesciences Corp 29,100 3,092,308 1.810%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil